CIPLA
Back to Cashflow Statement
|
CIPLA Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-1,293 Cr | ₹-1,200 Cr | ₹-958 Cr | ₹-1,600 Cr | ₹-1,240 Cr |
What is the latest Cash Flow from Financing Activities ratio of CIPLA ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-1,293 Cr |
| Mar2024 | ₹-1,200 Cr |
| Mar2023 | ₹-958 Cr |
| Mar2022 | ₹-1,600 Cr |
| Mar2021 | ₹-1,240 Cr |
How is Cash Flow from Financing Activities of CIPLA Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-1,293 Cr | Negative | |
| Mar2024 | ₹-1,200 Cr | Negative | |
| Mar2023 | ₹-958 Cr | Negative | |
| Mar2022 | ₹-1,600 Cr | Negative | |
| Mar2021 | ₹-1,240 Cr | - | |
Compare Cash Flow from Financing Activities of peers of CIPLA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CIPLA | ₹108,863.2 Cr | 1.6% | 1.8% | -7.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹417,028.0 Cr | 0.3% | 9% | 8.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,237.0 Cr | 1.9% | 5.9% | 12.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹146,801.0 Cr | 0.6% | 9.5% | 45% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,435.0 Cr | -1.5% | 5.7% | 14.5% | Stock Analytics | |
| MANKIND PHARMA | ₹92,784.1 Cr | 9.9% | 5.8% | -2% | Stock Analytics | |
CIPLA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CIPLA | 1.6% |
1.8% |
-7.9% |
| SENSEX | -1.8% |
-1.6% |
7.3% |
You may also like the below Video Courses